Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Kinetics of ivacaftor at Switch Orkambi Symkevi study
2019-001314-41Phase 4Terminated
- Start
- May 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of ivacaftor in cystic fibrosis (CF). Primary endpoint: Ivacaftor trough concentration. Started May 2019; status: terminated.
02
Drugs
ivacaftor
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on 2019-001314-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-001314-41.